GSK and Novartis bag big Japanese H1N1 vaccine contract
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline and Novartis have emerged as the two foreign suppliers of vaccines against pandemic influenza A (H1N1) swine flu to the Japanese government.